why choose us

First received: May 12, 2023

Clinical Trial: Identifying Ideal Reimbursement "Dose" to Reduce Clinical Trial-related Financial Toxicity

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Breast Cancer

Study Type: INTERVENTIONAL


Official Title: Identifying Ideal Reimbursement "Dose" to Reduce Clinical Trial-related Financial Toxicity

Brief Summary: The goal of this clinical trial is to identify the recommended financial reimbursement amount for women with breast cancer enrolled in a clinical trial.The main questions it aims to answer are:What is the recommended financial reimbursement amount in trial-enrolled women with breast cancer experiencing financial toxicity?What do patients think about receiving a reimbursement for trial-incurred expenses?Participants will receive a monthly reimbursement to compensate for their trial-incurred expenses in cohorts,…

Read more